Search Results - "Pulsipher MA"

Hepatic Effects, Potential Drug-Induced Liver Injury, and Other Liver Safety Considerations of Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in the New Era of Expanding Non-oncology Indications: Literature Review and Expert Consensus.

Authors: Fettiplace A Regev A Kiazand A et al.

Source: Drug safety [Drug Saf] 2026 Jun; Vol. 49 (6), pp. 631-654. Date of Electronic Publication: 2025 Dec 04.

Publication Type: Consensus Statement; Journal Article; Review

Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 9002928 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1942 (Electronic) Linking ISSN: 01145916 NLM ISO Abbreviation: Drug Saf Subsets: MEDLINE

The quintessential role for CAR T cell therapy in children, adolescents and young adults with cancer.

Authors: Schultz L McNerney K Lamble AJ et al.

Source: Nature reviews. Clinical oncology [Nat Rev Clin Oncol] 2026 Apr; Vol. 23 (4), pp. 260-278. Date of Electronic Publication: 2026 Jan 23.

Publication Type: Journal Article; Review

Journal Info: Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101500077 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1759-4782 (Electronic) Linking ISSN: 17594774 NLM ISO Abbreviation: Nat Rev Clin Oncol Subsets: MEDLINE

Safety and efficacy of CD19-targeted CAR-T-cell therapy for patients with relapsed or refractory TCF3-PBX1 fusion gene-positive B-ALL.

Authors: Huang, Can Teng, Yuanyin Yang, Tingting et al.

Source: Hematology. Dec2025, Vol. 30 Issue 1, p1-9. 9p.

Anti-CD19 chimeric antigen receptor T-cell therapy in a highly sensitized patient with focal and segmental glomerulosclerosis.

Authors: Guzzo, Isabella Becilli, Marco Cappoli, Andrea et al.

Source: Pediatric Nephrology. Nov2025, Vol. 40 Issue 11, p3513-3519. 7p.

Mesothelin-targeted CAR-T cells secreting NKG2D-BiTEs exhibit potent efficacy against triple-negative breast cancer.

Authors: Saliu, Muhammad Auwal Wang, Qi Salisu, Mansur Dabai et al.

Source: Experimental Hematology & Oncology. 3/3/2025, Vol. 14 Issue 1, p1-4. 4p.

The emerging role of immunotherapy in improving outcomes in Down syndrome - associated acute lymphoblastic leukemia: an insightful review.

Authors: Mohammed Saleh, Mostafa F. Nasiri, Abdulrahman Kotb, Ahmed et al.

Source: Leukemia & Lymphoma. Feb2026, Vol. 67 Issue 3, p481-488. 8p.

Spectrum of Primary Immune Regulatory Disorders in Children in a Highly Consanguineous Population: Report from a National Registry.

Authors: Alajmi A Alsharidah S Khalifa N et al.

Source: Journal of clinical immunology [J Clin Immunol] 2026 Feb 14; Vol. 46 (1). Date of Electronic Publication: 2026 Feb 14.

Publication Type: Journal Article

Journal Info: Publisher: Springer Country of Publication: Netherlands NLM ID: 8102137 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-2592 (Electronic) Linking ISSN: 02719142 NLM ISO Abbreviation: J Clin Immunol Subsets: MEDLINE

A second round of anti-CD19 CAR T-cell therapy in diffuse large B-cell lymphoma: when persistence pays off.

Authors: Leroy, Marie Deramoudt, Laure Pinturaud, Marine et al.

Source: Leukemia & Lymphoma. Jun2024, Vol. 65 Issue 6, p868-871. 4p.

Congenital erythropoietic porphyria: A case report and a review of the literature.

Authors: Bejja, Ikrame Baybay, Hanane Elloudi, Sara et al.

Source: Our Dermatology Online / Nasza Dermatologia Online. Jan2026, Vol. 17 Issue 1, p88-91. 4p.

Spatio-temporal kinetics of patients' CAR-T cells in blood and serous cavity effusion: real-world clinical insights.

Authors: Zhang, Man Chen, Caixia Fang, Yuekun et al.

Source: Cellular Oncology (2211-3428). Dec2025, Vol. 48 Issue 6, p1955-1969. 15p.

Elevated plasma CXCL9 and CHI3L1 prior to HCT predict post‐HCT lung complications in children.

Authors: Walker, Hannah Gubbels, Liam Haeusler, Gabrielle M et al.

Source: Clinical & Translational Immunology. 2025, Vol. 14 Issue 12, p1-13. 13p.

Latency between detectable low-level MRD by next-generation sequencing and overt relapse in ALL: implications for the optimal frequency of MRD monitoring.

Authors: Jamison, Trevor Jabbour, Elias Karrar, Omer et al.

Source: Leukemia & Lymphoma. May2026, p1-4. 4p. 1 Illustration.

Adoptive T‐cell therapies in the clinic.

Authors: Shaha, Suyog Lourenco, Leah Zhao, Zongmin et al.

Source: Bioengineering & Translational Medicine. May2026, Vol. 11 Issue 3, p1-32. 32p.

CAR‐T from cord blood in a patient with Ph+ acute lymphoblastic leukemia relapsing after hematopoietic stem cell transplantation.

Authors: Marra, John Donald Galli, Eugenio Giammarco, Sabrina et al.

Source: European Journal of Haematology. Jul2024, Vol. 113 Issue 1, p127-129. 3p.

Autologous stem cell transplantation for adults with Philadelphia-negative acute lymphoblastic leukemia in first complete remission. A study by the Acute Leukemia Working Party of the EBMT.

Authors: Swoboda, Ryszard Labopin, Myriam Giebel, Sebastian et al.

Source: BMC Cancer. 4/28/2025, Vol. 25 Issue 1, p1-12. 12p.

Mathematical modeling unveils the timeline of CAR-T cell therapy and macrophage-mediated cytokine release syndrome.

Authors: Santurio, Daniela S Barros, Luciana R C Glauche, Ingmar et al.

Source: PLoS Computational Biology. 4/9/2025, Vol. 21 Issue 4, p1-32. 32p.

Healing bonds: the complex experiences of pediatric sibling stem cell donors.

Authors: Thys, Camie Devos, Patricia Goubert, Liesbet et al.

Source: European Journal of Pediatrics. Apr2025, Vol. 184 Issue 4, p1-7. 7p.

Emerging Roles of Fc Receptor-Like 1 in Immunotherapy of Diffuse Large B-Cell Lymphoma.

Authors: Blumenstock, Kayce Zaman, Vandana Green, Camille et al.

Source: Biocell. 2025, Vol. 49 Issue 10, p1859-1871. 13p.

pH-responsive activation of Tet-On inducible CAR-T cells enables spatially selective treatment of targeted solid tumors at reduced safety risk.

Authors: Liu, Yan Hao, Yu Zhang, Jin et al.

Source: National Science Review. Sep2025, Vol. 12 Issue 9, p1-15. 15p.

Challenges and advances in CAR-T cell therapy for B-ALL.

Authors: Zha C Wang Y

Source: Biomarker research [Biomark Res] 2026 May 18; Vol. 14 (1). Date of Electronic Publication: 2026 May 18.

Publication Type: Journal Article; Review

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101607860 Publication Model: Electronic Cited Medium: Print ISSN: 2050-7771 (Print) Linking ISSN: 20507771 NLM ISO Abbreviation: Biomark Res Subsets: PubMed not MEDLINE